Libtayo (cemiplimab)

pCPA File Number: 22887

Negotiation Status:

Concluded with an LOI

Indication(s):

For the treatment of patients with locally advanced basal cell carcinoma (BCC) previously treated with a hedgehog pathway inhibitor

Sponsor/Manufacturer:

Regeneron

CDA-AMC Project Number:

Not Applicable

pCPA Engagement Letter Issued:

2024-08-30

Negotiation Process Concluded:

2025-03-03